These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3321944)

  • 1. IgA antibody to group specific polysaccharide in secretions of carriers and noncarriers of group B streptococci.
    Marxmiller JN; Gray BM; Anthony BF
    Adv Exp Med Biol; 1987; 216B():989-94. PubMed ID: 3321944
    [No Abstract]   [Full Text] [Related]  

  • 2. Human antibody to the group-specific polysaccharide of group B Streptococcus.
    Anthony BF; Concepcion NF; Concepcion KF
    J Infect Dis; 1985 Feb; 151(2):221-6. PubMed ID: 3881538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific antibodies against group B streptococci in human serum, saliva and vaginal secretions.
    Gray BM; Dillon HC; Pritchard DG; Feinstein RA; Oh K; Michalek SM
    Adv Exp Med Biol; 1987; 216B():995-1003. PubMed ID: 3321945
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
    Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
    Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
    Baker CJ; Rench MA; Kasper DL
    N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.
    Matsubara K; Katayama K; Baba K; Nigami H; Harigaya H
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):453-4. PubMed ID: 12827529
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroepidemiology of group B streptococcus type III colonization at delivery.
    Gray BM; Pritchard DG; Dillon HC
    J Infect Dis; 1989 Jun; 159(6):1139-42. PubMed ID: 2656881
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of screening test for prevention of neonatal infection due to group B Streptococcus].
    Suzuki Y; Hoshina K; Ito T; Amano Y; Onogawa T
    Kansenshogaku Zasshi; 1988 Oct; 62(10):911-5. PubMed ID: 3145313
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitation of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1b in pregnant women and infected infants.
    Gotoff SP; Papierniak CK; Klegerman ME; Boyer KM
    J Pediatr; 1984 Oct; 105(4):628-30. PubMed ID: 6207281
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is the purpose of mucosal antibodies? Relevance to colonization with group B streptococci].
    Hordnes K; Jonsson R; Brandtzaeg P; Haneberg B
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4109-13. PubMed ID: 9441448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group B streptococcal infection in humans.
    Wilkinson HW
    Annu Rev Microbiol; 1978; 32():41-57. PubMed ID: 360972
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody levels in mothers colonised with group B streptococci during pregnancy and in their newborn infants, as measured by an enzyme linked immunosorbent assay.
    Cleat PH; Ross J; Needham JR
    Med Microbiol Immunol; 1980 Feb; 168(1):49-53. PubMed ID: 6991897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitation of IgG antibodies to type Ia group B streptococcal type-specific polysaccharides measured by enzyme-linked immunosorbent assay].
    Sugiyama M; Kojima M; Yasuda Y; Hori Y; Nishiyama Y; Sugiyama A; Kido N; Ota M
    Kansenshogaku Zasshi; 1990 Jul; 64(7):840-6. PubMed ID: 2230372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic carrier state in mothers of infants with group B streptococcal infections.
    Dykes AK; Christensen KK; Christensen P
    Obstet Gynecol; 1985 Jul; 66(1):84-8. PubMed ID: 3892391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization of mothers of infants with neonatal GBS infection: definition of a risk group.
    Christensen KK; Christensen P
    Antibiot Chemother (1971); 1985; 35():190-3. PubMed ID: 3901895
    [No Abstract]   [Full Text] [Related]  

  • 18. Group-B streptococcus--profile of an organism.
    Ross PW
    J Med Microbiol; 1984 Oct; 18(2):139-66. PubMed ID: 6387125
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.
    Baker CJ; Webb BJ; Kasper DL; Yow MD; Beachler CW
    Am J Obstet Gynecol; 1980 May; 137(1):39-42. PubMed ID: 6989248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic factors in group B streptococci types IV and V.
    Orefici G; Molinari A; Von Hunolstein C; Donelli G; Paradisi S; Recchia S; Arancia G
    Chemioterapia; 1987 Jun; 6(2 Suppl):19-21. PubMed ID: 3334555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.